Should I take ursodeoxycholic acid while taking Seladelpar?
Seladelpar is a selective bile acid receptor modulator, mainly used to treat cholestasis-related diseases such as primary biliary cholangitis (PBC). Regarding whether it is necessary to take ursodeoxycholic acid (UDCA) simultaneously while using Siladepa, there are certain clinical guidelines and practical experience, which are explained in detail below.
First of all, as the current standard treatment for PBC, ursodeoxycholic acid can promote bile flow, reduce liver inflammation and prevent liver fibrosis. Most PBC patients will first receive UDCA treatment after diagnosis, and Siladepa is often used as a replacement or addition to patients who have an insufficient response to or cannot tolerate UDCA.

Secondly, some clinical studies have shown that Siladepa can be used alone or in combination with UDCA. When used in combination, the two mechanisms complement each other and may lead to better therapeutic effects. Whether combined use is necessary should be determined based on the patient's liver function status, disease progression and tolerance to UDCA. If the patient is able to tolerate UDCA and the effect is not satisfactory, the doctor may recommend combined medication; for those who are UDCA intolerant, Siladepa can also be used as a single-drug treatment.
Finally, regardless of whether the drug is used alone or in combination, patients should regularly monitor liver function indicators and cholestasis-related indicators during use to ensure that the treatment is safe and effective. The specific plan should follow the doctor's guidance and avoid self-adjustment of medication to achieve optimal disease control and improvement of quality of life.
In summary, whether to take ursodeoxycholic acid at the same time during the use of Siladepa needs to be based on the patient's specific condition and the doctor's advice. The two can be used alone or in combination, and both have certain clinical basis and practical experience support.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)